All-trans Retinoic Acid
Drug timelines are a Plus or Pro feature.
42 regulatory and trial events tracked for All-trans Retinoic Acid, covering 2008-03-04 to 2026-03-31. Get the full timeline:
Most recent: Clinical Trial Update: Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL). [Phase 3]